A Peptide HEPFYGNEGALR from Alleviates Acute Alcoholic Liver Injury by Enhancing Antioxidant Response in Male C57BL/6J Mice
Affiliations
Liver-related disease caused by alcohol is a frequent disorder of the hepatic tract. Heavy consumption of alcohol in a short period causes oxidative damage to the liver. Sea cucumber is abundant in nutrients and its various extracts have been studied for antioxidant properties. One peptide was isolated and identified from in our recent study. We investigated the benefits of the peptide in a model of acute ethanol-induced male C57BL/6J mice. Dietary intake of the peptide could attenuate hepatomegaly, hepatitis and the accumulation of lipid droplets, and increase antioxidant enzyme activities in mice with acute alcoholic liver injury. The results indicated that a 20 mg/kg peptide supplement could activate the Nrf2/HO-1 pathway and block the nuclear translocation of NF-κB to alleviate oxidative stress and inflammation. In addition, the preventive effects of peptide supplementation may be related to autophagy. This study suggests that dietary supplementation with a sea cucumber-derived peptide is one of the potential candidates to alleviate acute alcoholic liver injury.
Liu X, Hu Q, Shen Y, Wu Y, Gao L, Xu X Metabolites. 2024; 14(10).
PMID: 39452942 PMC: 11510070. DOI: 10.3390/metabo14100561.
Advances in the application and mechanism of bioactive peptides in the treatment of inflammation.
Liu H, Zhang L, Yu J, Shao S Front Immunol. 2024; 15:1413179.
PMID: 39247182 PMC: 11377253. DOI: 10.3389/fimmu.2024.1413179.
Efficacy of Decne. Aqueous extract in mice with acute alcoholic liver injury and metabolomic study.
Meng X, Ren K, Liu X, Lyu C, Jung H, Zhang Y Heliyon. 2024; 10(12):e32523.
PMID: 38952369 PMC: 11215275. DOI: 10.1016/j.heliyon.2024.e32523.
Gu X, Zhao R, Li H, Dong X, Meng M, Li T Foods. 2024; 13(2).
PMID: 38254563 PMC: 10814447. DOI: 10.3390/foods13020262.
Research progress on the chemical components and biological activities of sea cucumber polypeptides.
Shou Y, Feng C, Lu Q, Mao X, Huang H, Su Z Front Pharmacol. 2023; 14:1290175.
PMID: 37908979 PMC: 10613643. DOI: 10.3389/fphar.2023.1290175.